The concentration of adenosine 3',5'-monophosphate (cyclic AMP) and the activity of adenylate cyclase were determined for the first time in conjunction with cyclic 3 ',5'-nucleotide phosphodiesterase (phosphodiesterase) The ciliated protozoan, Tetrahymena pyriformis, offers a model system for the study of the evolutionary development of adenosine 3',5'-cyclic monophosphate (cyclic AMP) as a regulatory agent in intermediary metabolism. This unicellular organism synthesizes and stores large glycogen reserves through gluconeogenesis or glycogenesis if the growth medium is supplemented with glucose. In addition, the presence of an intracellular metabolic control system, perhaps similar to that in mammals, is suggested by the finding of both catecholamines (10) and serotonin (9) in Tetrahymena, and by the fact that glycogen content and phosphorylase activity are affected by several adrenergic reactive drugs (2). In this communication, cyclic AMP and adenylate cyclase are identified for the first time in Tetrahymena, and the presence of a cyclic 3', 5'-nucleotide phosphodiesterase (phosphodiesterase) is confirmed (3). Changes in the level of cyclic AMP in Tetrahymena during growth indicate the similarities to, as well as important differences from, higher animals as to the role this nucleotide plays in the regulation of cell metabolism.
The ciliated protozoan, Tetrahymena pyriformis, offers a model system for the study of the evolutionary development of adenosine 3',5'-cyclic monophosphate (cyclic AMP) as a regulatory agent in intermediary metabolism. This unicellular organism synthesizes and stores large glycogen reserves through gluconeogenesis or glycogenesis if the growth medium is supplemented with glucose. In addition, the presence of an intracellular metabolic control system, perhaps similar to that in mammals, is suggested by the finding of both catecholamines (10) and serotonin (9) in Tetrahymena, and by the fact that glycogen content and phosphorylase activity are affected by several adrenergic reactive drugs (2) . In this communication, cyclic AMP and adenylate cyclase are identified for the first time in Tetrahymena, and the presence of a cyclic 3', 5'-nucleotide phosphodiesterase (phosphodiesterase) is confirmed (3) . Changes in the level of cyclic AMP in Tetrahymena during growth indicate the similarities to, as well as important differences from, higher animals as to the role this nucleotide plays in the regulation of cell metabolism.
(A portion of this work is from a dissertation submitted by the senior author in partial fulfill- ' Phosphopyruvate carboxylase assay. Phosphopyruvate carboxylase was assayed, by a previously described method (18) , on the cytosol fraction prepared by centrifuging 0.25 M sucrose homogenates of cells at 100,000 x g for 60 min.
Glycogen, which was precipitated by adding 95% ethanol to a boiled alkaline hydrolysate of washed cells, was determined by the anthrone procedure (14) . Protein was measured by the biuret method (8 Additional experiments were done to more precisely determine the relationship of adenylate cyclase and phosphodiesterase with cyclic AMP in these cultures (Fig. 2) . Adenylate cyclase declines during early linear growth (as do intracellular cyclic AMP levels) and reaches its nadir at about 72 h when the culture is at the early stationary phase on the growth curve (Fig.  1) . A subsequent sharp increase in activity then (18) and rat liver (19) , the cytosol enzyme increases concomitantly with overall gluconeogenesis. Administration of cyclic AMP or the dibutryl derivative to rats causes a marked increase in the liver enzyme (12, 21 by several hormones (20) , there is little evidence other than the present experiments to suggest that the enzyme is responsive to catabolite repression by glucose. In fact, studies in Escherichia coli indicate that adenylate cyclase and phosphodiesterase activities do not vary in response to glucose concentration (16) .
DISCUSSION
The importance of cyclic AMP as an effector of cell metabolism in most organisms, including bacteria, is well established (20) . Cyclic AMP in mammals is postulated to act through activation of a protein kinase which, in turn. phosphorylates and thereby activates or inactivates a critical enzyme. In the extensively studied lac operon system of E. coli, however, cyclic AMP does not appear to prevent catabolite repression of f,-galactosidase by such a mechanism (15).
In bacteria, cyclic AMP combines with a specific receptor protein similar to the regulatory subunit of protein kinase, and this complex apparently affects protein synthesis at the transcription level.
Except for the effects on catabolite repression in bacteria (15) and the aggregation phenomena in the slime mold (1), the overall physiological function of cyclic AMP and control of its metabolism in unicellular organisms have not been extensively studied. For the most part, such studies have been carried out in multicellular animals, and, within the concept of the second messenger hypothesis, one otf the chief functions of cyclic AMP seems to be to promote mobilization of energy-yielding substrates from their sites of storage (20) . The most striking by evidence showing lower levels of this nucleotide in organisms grown in glucose-supplemented media (13) as well as in rat liver perfused with glucose and insulin (11) . In Tetrahymena the temporal relationship of elevated adenylate cyclase and cyclic AMP level in early exponential growth imply an important effect of this nucleotide on some metabolic parameter associated with protein synthesis and cell division. In recent studies (unpublished data), the activity of a cyclic AMP-dependent protein kinase has been found to follow the same pattern as cyclic AMP during the growth curve shown here.
In the context of the proposed physiological function of cyclic AMP in mammals, the present results depicting its reciprocal relationship to carbohydrate synthesis may initially appear anomalous, but, on further examination, are actually consistent with the metabolism of Tetrahymena. In mammals, high levels of cyclic AMP are necessary to maintain blood glucose by gluconeogenesis and glycogenolysis. The in vitro addition of this nucleotide to perfused liver stimulates the synthesis of glucose (7) , whereas injection into the intact animal induces formation of certain gluconeogenic enzymes (12) . However, in Tetrahymena, glycogen, not glucose, is the final product of gluconeogenesis. High levels of cyclic AMP during gluconeogenesis would inevitably inhibit the glycogen synthetase enzyme, thereby acting as an inhibitor of net glycogen formation. Thus, cyclic AMP remains low until late stationary growth when glycogen is utilized for energy and the nucleotide is necessary to stimulate the phosphorylase enzyme system. It thus appears appropriate for Tetrahymena that regulation of carbohydrate metabolism by cyclic AMP occurs at the level of the glycogen synthetase and phosphorylase enzymes. The positive effect of cyclic AMP on liver gluconeogenesis somewhere between pyruvate and phosphopyruvate (7) with its concomitant induction of the key gluconeogenic enzyme phosphopyruvate carboxylase (12) has been demonstrated in mammals. This control system appears to have occurred later in evolution with the development of discrete organs to carry out various metabolic sequences. UJnless there was adequate compartmentation, it would be inappropriate for a unicellular organism, such as Tetrahymena, to have cyclic AMP act as a positive effector on gluconeogenesis at the level of phosphopyruvate formation while its negative effect occurs simultaneously at the glycogen synthetase step.
